Helmut Schröder1, Maria Dolors Zomeño2, Miguel Angel Martínez-González3, Jordi Salas-Salvadó4, Dolores Corella5, Jesús Vioque6, Dora Romaguera7, J Alfredo Martínez8, Francisco J Tinahones9, José López Miranda10, Ramon Estruch11, Aurora Bueno-Cavanillas12, Angel M Alonso Gómez13, Josep A Tur14, Julia Warnberg15, Lluis Serra-Majem16, Vicente Martín17, Clotilde Vázquez18, José Lapetra19, Xavier Pintó20, Josep Vidal21, Lidia Daimiel22, José Juan Gaforio23, Pilar Matía-Martín24, Emilio Ros25, Camille Lassale26, Miguel Ruiz-Canela27, Nancy Babio4, José V Sorlí5, Ana García-Arellano28, Andrés Díaz-López29, Montserrat Fitó30, Olga Castañer30. 1. Cardiovascular Risk and Nutrition Research Group, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain. Electronic address: hschroeder@imim.es. 2. Cardiovascular Risk and Nutrition Research Group, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, Spain; Programa de Doctorado en Alimentación y Nutrición, Facultad de Farmacia, Universidad de Barcelona, Barcelona, Spain. 3. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; University of Navarra, Department of Preventive Medicine and Public Health, IDISNA, Pamplona, Spain; Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, USA. 4. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Universitat Rovira i Virgili, Departament de Bioquimica i Biotecnologia, Unitat de Nutrició Humana, IISPV, Hospital Universitari de Sant Joan de Reus, 43201, Reus, Spain. 5. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Department of Preventive Medicine, University of Valencia, Valencia, Spain. 6. CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Miguel Hernández University, Instituto de Investigación Sanitaria y Biomédica de Alicante, ISABIAL-UMH, Alicante, Spain. 7. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain. 8. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Cardiometabolic Nutrition Program, IMDEA Food, CEI UAM + CSIC, Madrid, Spain; Department of Nutrition, Food Sciences, and Physiology, Center for Nutrition Research, University of Navarra, Pamplona, Spain. 9. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Virgen de La Victoria Hospital, Department of Endocrinology, University of Málaga, Málaga, Spain. 10. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Lipids and Atherosclerosis Unit, Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Reina Sofia University Hospital, University of Cordoba, Córdoba, Spain. 11. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Department of Internal Medicine, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain. 12. CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Department of Preventive Medicine and Public Health, University of Granada, Granada. 13. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU, Vitoria-Gasteiz, Spain. 14. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Health Research Institute of the Balearic Islands (IdISBa), Palma de Mallorca, Spain; Research Group on Community Nutrition & Oxidative Stress, University of Balearic Islands, Palma de Mallorca, Spain. 15. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Department of Nursing, School of Health Sciences, University of Málaga-IBIMA, Málaga, Spain. 16. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Institute for Biomedical Research, University of Las Palmas de Gran Canarias, 35016, Las Palmas, Spain. 17. CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Instituto de Biomedicina (IBIOMED), Universidad de León, León, Spain. 18. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Department of Endocrinology and Nutrition, Hospital Fundación Jimenez Díaz, Instituto de Investigaciones Biomédicas IISFJD. University Autonoma, Madrid, Spain. 19. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Department of Family Medicine, Research Unit, Distrito Sanitario Atención Primaria Sevilla, Sevilla, Spain. 20. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Lipids and Vascular Risk Unit, Internal Medicine, Hospital Universitario de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain. 21. CIBER Diabetes y Enfermedades Metabólicas (CIBERDEM), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Department of Endocrinology, Institut D'Investigacions Biomédiques August Pi Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, Barcelona, Spain. 22. Nutritional Control of the Epigenome Group, Precision Nutrition and Obesity Program, IMDEA Food, CEI UAM + CSIC, Madrid, Spain. 23. CIBER Epidemiología y Salud Pública (CIBERESP), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Department of Health Sciences, Center for Advanced Studies in Olive Grove and Olive Oils, University of Jaen, Jaen, Spain. 24. Department of Endocrinology and Nutrition, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC), Madrid, Spain. 25. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Lipid Clinic, Department of Endocrinology and Nutrition, Institut D'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, Barcelona, Spain. 26. Cardiovascular Risk and Nutrition Research Group, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, Spain. 27. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; University of Navarra, Department of Preventive Medicine and Public Health, IDISNA, Pamplona, Spain. 28. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; University of Navarra, Department of Preventive Medicine and Public Health, IDISNA, Pamplona, Spain; Emergency Department, Complejo Hospitalario de Navarra, Servicio Navarro de Salud-Osaunbidea, Spain. 29. CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain; Serra Hunter Fellow, Universitat Rovira I Virgili, Departament de Ciències Mèdiques Bàsiques, Nutrition and Mental Health Research Group (NUTRISAM), Reus, Spain; Institut D'Investigació Sanitària Pere Virgili (IISPV), Reus, Spain. 30. Cardiovascular Risk and Nutrition Research Group, Hospital Del Mar Medical Research Institute (IMIM), Barcelona, Spain; CIBER Fisiopatología de La Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
Abstract
BACKGROUND: Short dietary assessment tools can be useful to estimate food intake and diet quality in large-scale epidemiological studies with time constraints. OBJECTIVE: To determine the concurrent validity of the 17-item energy-restricted Mediterranean Adherence Screener (er-MEDAS) used in the PREDIMED (PREvención con DIeta MEDiterránea)-Plus trial and to analyse its capacity to detect 1-year changes in diet and cardiometabolic risk factors. METHODS: Validation study nested in the PREDIMED-Plus (n = 6760, 55-75 years). Dietary data were collected by the 17-item er-MEDAS and a 143-item validated semiquantitative food frequency questionnaire (FFQ) at baseline and after 1-year intervention. Cardiometabolic risk markers were measured at both time points. A Mediterranean diet (MedDiet) score was derived from both instruments. Concurrent validity was evaluated by Pearson and intra-class correlation coefficients (ICC) and Bland and Altman limits of agreement. Construct validity was evaluated by assessing 1-year changes in FFQ-reported dietary intake and cardiometabolic profile changes in relation to changes in er-MEDAS. RESULTS: A moderate to good correlation between the MedDiet score calculated by both measurement instruments was found: r = 0.61 and ICC = 0.60 (both p < 0.001). Agreement of each of the er-MEDAS items ranged from 55.4% to 85.0% with a moderate mean concordance (kappa = 0.41). Between baseline and 1-year follow-up, energy intake measured by the FFQ decreased by 242 kcal, while Mediterranean food consumption increased in participants with the highest increase in the er-MEDAS MedDiet score. An increase in the er-MEDAS MedDiet score ratings was associated with a decrease in BMI, waist circumference, triglycerides, fasting glucose, diastolic blood pressure, and triglycerides/HDL-cholesterol ratio (p < 0.001 for all), and with an increase in HDL-cholesterol (p = 0.006). CONCLUSION: The er-MEDAS shows a modest to good concurrent validity compared with FFQ data. It shows acceptable construct validity, as a greater er-MEDAS score was associated with more favourable dietary and cardiometabolic profiles over time. TRIAL REGISTRY: ISRCTN89898870; registration date, 24 July 2014. https://www.isrctn.com/ISRCTN89898870.
BACKGROUND: Short dietary assessment tools can be useful to estimate food intake and diet quality in large-scale epidemiological studies with time constraints. OBJECTIVE: To determine the concurrent validity of the 17-item energy-restricted Mediterranean Adherence Screener (er-MEDAS) used in the PREDIMED (PREvención con DIeta MEDiterránea)-Plus trial and to analyse its capacity to detect 1-year changes in diet and cardiometabolic risk factors. METHODS: Validation study nested in the PREDIMED-Plus (n = 6760, 55-75 years). Dietary data were collected by the 17-item er-MEDAS and a 143-item validated semiquantitative food frequency questionnaire (FFQ) at baseline and after 1-year intervention. Cardiometabolic risk markers were measured at both time points. A Mediterranean diet (MedDiet) score was derived from both instruments. Concurrent validity was evaluated by Pearson and intra-class correlation coefficients (ICC) and Bland and Altman limits of agreement. Construct validity was evaluated by assessing 1-year changes in FFQ-reported dietary intake and cardiometabolic profile changes in relation to changes in er-MEDAS. RESULTS: A moderate to good correlation between the MedDiet score calculated by both measurement instruments was found: r = 0.61 and ICC = 0.60 (both p < 0.001). Agreement of each of the er-MEDAS items ranged from 55.4% to 85.0% with a moderate mean concordance (kappa = 0.41). Between baseline and 1-year follow-up, energy intake measured by the FFQ decreased by 242 kcal, while Mediterranean food consumption increased in participants with the highest increase in the er-MEDAS MedDiet score. An increase in the er-MEDAS MedDiet score ratings was associated with a decrease in BMI, waist circumference, triglycerides, fasting glucose, diastolic blood pressure, and triglycerides/HDL-cholesterol ratio (p < 0.001 for all), and with an increase in HDL-cholesterol (p = 0.006). CONCLUSION: The er-MEDAS shows a modest to good concurrent validity compared with FFQ data. It shows acceptable construct validity, as a greater er-MEDAS score was associated with more favourable dietary and cardiometabolic profiles over time. TRIAL REGISTRY: ISRCTN89898870; registration date, 24 July 2014. https://www.isrctn.com/ISRCTN89898870.
Authors: Rocío Zamanillo-Campos; Alice Chaplin; Dora Romaguera; Itziar Abete; Jordi Salas-Salvadó; Vicente Martín; Ramón Estruch; Josep Vidal; Miguel Ruiz-Canela; Nancy Babio; Francisca Fiol; José Antonio de Paz; Rosa Casas; Romina Olbeyra; Miguel A Martínez-González; Jesús F García-Gavilán; Albert Goday; Cesar I Fernandez-Lazaro; J Alfredo Martínez; Frank B Hu; Jadwiga Konieczna Journal: Clin Nutr Date: 2022-08-20 Impact factor: 7.643
Authors: Alessandro Atzeni; Thomaz F S Bastiaanssen; John F Cryan; Francisco J Tinahones; Jesús Vioque; Dolores Corella; Montserrat Fitó; Josep Vidal; Isabel Moreno-Indias; Ana M Gómez-Pérez; Laura Torres-Collado; Oscar Coltell; Olga Castañer; Monica Bulló; Jordi Salas-Salvadó Journal: Front Endocrinol (Lausanne) Date: 2022-04-28 Impact factor: 6.055
Authors: Cristina Valle-Hita; Andrés Díaz-López; Nerea Becerra-Tomás; Miguel A Martínez-González; Verónica Ruiz García; Dolores Corella; Albert Goday; J Alfredo Martínez; Ángel M Alonso-Gómez; Julia Wärnberg; Jesús Vioque; Dora Romaguera; José López-Miranda; Ramon Estruch; Francisco J Tinahones; José Lapetra; Luís Serra-Majem; Naomi Cano-Ibáñez; Josep A Tur; María Rubín-García; Xavier Pintó; Miguel Delgado-Rodríguez; Pilar Matía-Martín; Josep Vidal; Sebastian Mas Fontao; Lidia Daimiel; Emilio Ros; Estefania Toledo; José V Sorlí; C Roca; Iztiar Abete; Anai Moreno-Rodriguez; Edelys Crespo-Oliva; Inmaculada Candela-García; Marga Morey; Antonio Garcia-Rios; Rosa Casas; Jose Carlos Fernandez-Garcia; José Manuel Santos-Lozano; Javier Diez-Espino; Carolina Ortega-Azorín; M Comas; M Angeles Zulet; Carolina Sorto-Sanchez; Miguel Ruiz-Canela; Montse Fitó; Jordi Salas-Salvadó; Nancy Babio Journal: Eur J Nutr Date: 2022-04-02 Impact factor: 4.865
Authors: Celia Martinez-Perez; Lidia Daimiel; Cristina Climent-Mainar; Miguel Ángel Martínez-González; Jordi Salas-Salvadó; Dolores Corella; Helmut Schröder; Jose Alfredo Martinez; Ángel M Alonso-Gómez; Julia Wärnberg; Jesús Vioque; Dora Romaguera; José López-Miranda; Ramón Estruch; Francisco J Tinahones; José Lapetra; Lluis Serra-Majem; Aurora Bueno-Cavanillas; Josep A Tur; Vicente Martín Sánchez; Xavier Pintó; Miguel Delgado-Rodríguez; Pilar Matía-Martín; Josep Vidal; Clotilde Vázquez; Emilio Ros; Javier Basterra; Nancy Babio; Patricia Guillem-Saiz; María Dolores Zomeño; Itziar Abete; Jessica Vaquero-Luna; Francisco Javier Barón-López; Sandra Gonzalez-Palacios; Jadwiga Konieczna; Antonio Garcia-Rios; María Rosa Bernal-López; José Manuel Santos-Lozano; Maira Bes-Rastrollo; Nadine Khoury; Carmen Saiz; Karla Alejandra Pérez-Vega; María Angeles Zulet; Lucas Tojal-Sierra; Zenaida Vázquez Ruiz; Maria Angeles Martinez; Mireia Malcampo; José M Ordovás; Rodrigo San-Cristobal Journal: Int J Behav Nutr Phys Act Date: 2022-01-24 Impact factor: 6.457
Authors: Anna Tresserra-Rimbau; Sara Castro-Barquero; Nerea Becerra-Tomás; Nancy Babio; Miguel Ángel Martínez-González; Dolores Corella; Montserrat Fitó; Dora Romaguera; Jesús Vioque; Angel M Alonso-Gomez; Julia Wärnberg; José Alfredo Martínez; Luís Serra-Majem; Ramon Estruch; Francisco J Tinahones; José Lapetra; Xavier Pintó; Josep A Tur; José López-Miranda; Naomi Cano-Ibáñez; Miguel Delgado-Rodríguez; Pilar Matía-Martín; Lidia Daimiel; Vicente Martín Sánchez; Josep Vidal; Clotilde Vázquez; Emili Ros; Francisco Javier Basterra; María Fernández de la Puente; Eva M Asensio; Olga Castañer; Vanessa Bullón-Vela; Lucas Tojal-Sierra; Enrique Gómez-Gracia; Eugenio Cases-Pérez; Jadwiga Konieczna; Antonio García-Ríos; Tamara Casañas-Quintana; María Rosa Bernal-Lopez; José Manuel Santos-Lozano; Virginia Esteve-Luque; Cristina Bouzas; Zenaida Vázquez-Ruiz; Antoni Palau-Galindo; Rocio Barragan; Mercè López Grau; Cristina Razquín; Leire Goicolea-Güemez; Estefanía Toledo; Manel Vila Vergaz; Rosa M Lamuela-Raventós; Jordi Salas-Salvadó Journal: Antioxidants (Basel) Date: 2022-02-04
Authors: Cesar I Fernandez-Lazaro; Estefanía Toledo; Pilar Buil-Cosiales; Jordi Salas-Salvadó; Dolores Corella; Montserrat Fitó; J Alfredo Martínez; Ángel M Alonso-Gómez; Julia Wärnberg; Jesús Vioque; Dora Romaguera; José López-Miranda; Ramon Estruch; Francisco J Tinahones; José Lapetra; Luís Serra-Majem; Aurora Bueno-Cavanillas; Josep A Tur; Vicente Martín Sánchez; Xavier Pintó; Miguel Delgado-Rodríguez; Pilar Matía-Martín; Josep Vidal; Emilio Ros; Clotilde Vázquez; Lidia Daimiel; Beatriz SanJulián; Jesús F García-Gavilán; Jose V Sorlí; Olga Castañer; M Ángeles Zulet; Lucas Tojal-Sierra; Napoleón Pérez-Farinós; Alejandro Oncina-Canovas; Manuel Moñino; Antonio Garcia-Rios; Emilio Sacanella; Rosa M Bernal-Lopez; José Manuel Santos-Lozano; Zenaida Vázquez-Ruiz; Jananee Muralidharan; Carolina Ortega-Azorín; Alberto Goday; Cristina Razquin; Leire Goicolea-Güemez; Miguel Ruiz-Canela; Nerea Becerra-Tomás; Helmut Schröder; Miguel A Martínez González Journal: Eur J Nutr Date: 2021-11-30 Impact factor: 5.614
Authors: Víctor Micó; Rodrigo San-Cristobal; Roberto Martín; Miguel Ángel Martínez-González; Jordi Salas-Salvadó; Dolores Corella; Montserrat Fitó; Ángel M Alonso-Gómez; Julia Wärnberg; Jesús Vioque; Dora Romaguera; José López-Miranda; Ramon Estruch; Francisco J Tinahones; José Lapetra; J Luís Serra-Majem; Aurora Bueno-Cavanillas; Josep A Tur; Vicente Martín Sánchez; Xavier Pintó; Miguel Delgado-Rodríguez; Pilar Matía-Martín; Josep Vidal; Clotilde Vázquez; Ana García-Arellano; Salvador Pertusa-Martinez; Alice Chaplin; Antonio Garcia-Rios; Carlos Muñoz Bravo; Helmut Schröder; Nancy Babio; Jose V Sorli; Jose I Gonzalez; Diego Martinez-Urbistondo; Estefania Toledo; Vanessa Bullón; Miguel Ruiz-Canela; María Puy- Portillo; Manuel Macías-González; Nuria Perez-Diaz-Del-Campo; Jesús García-Gavilán; Lidia Daimiel; J Alfredo Martínez Journal: Front Endocrinol (Lausanne) Date: 2022-09-06 Impact factor: 6.055
Authors: María Marhuenda-Muñoz; Inés Domínguez-López; Klaus Langohr; Anna Tresserra-Rimbau; Miguel Ángel Martínez González; Jordi Salas-Salvadó; Dolores Corella; María Dolores Zomeño; J Alfredo Martínez; Angel M Alonso-Gómez; Julia Wärnberg; Jesús Vioque; Dora Romaguera; José López-Miranda; Ramón Estruch; Francisco J Tinahones; José Lapetra; Ll Serra-Majem; Aurora Bueno-Cavanillas; Josep A Tur; Vicente Martín-Sánchez; Xavier Pintó; Miguel Delgado-Rodríguez; Pilar Matía-Martín; Josep Vidal; Clotilde Vázquez; Lidia Daimiel; Emilio Ros; Estefanía Toledo; María Fernández de la Puente Cervera; Rocío Barragán; Montse Fitó; Lucas Tojal-Sierra; Enrique Gómez-Gracia; Juan Manuel Zazo; Marga Morey; Antonio García-Ríos; Rosa Casas; Ana M Gómez-Pérez; José Manuel Santos-Lozano; Zenaida Vázquez-Ruiz; Alessandro Atzeni; Eva M Asensio; M Mar Gili-Riu; Vanessa Bullon; Anai Moreno-Rodriguez; Oscar Lecea; Nancy Babio; Francesca Peñas Lopez; Guadalupe Gómez Melis; Rosa M Lamuela-Raventós Journal: Front Nutr Date: 2022-09-29
Authors: Rebeca Fernández-Carrión; Jose V Sorlí; Oscar Coltell; Eva C Pascual; Carolina Ortega-Azorín; Rocío Barragán; Ignacio M Giménez-Alba; Andrea Alvarez-Sala; Montserrat Fitó; Jose M Ordovas; Dolores Corella Journal: Biomedicines Date: 2021-12-31